tradingkey.logo

Natural Alternatives International Inc

NAII
查看详细走势图
3.220USD
+0.070+2.22%
收盘 12/19, 16:00美东报价延迟15分钟
19.89M总市值
亏损市盈率 TTM

Natural Alternatives International Inc

3.220
+0.070+2.22%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+2.22%

5天

+2.22%

1月

+3.87%

6月

-2.72%

今年开始到现在

-25.29%

1年

-24.06%

查看详细走势图

操作建议

Natural Alternatives International Inc当前公司基本面数据相对稳定,增长潜力很大。当前估值合理,在药品行业排名120/158位。机构持股占比非常高,中期看,股价处于平稳状态。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Natural Alternatives International Inc评分

相关信息

行业排名
120 / 158
全市场排名
360 / 4582
所属行业
药品

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 0 位分析师
--
评级
--
目标均价
--
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Natural Alternatives International Inc亮点

亮点风险
Natural Alternatives International, Inc. is a formulator, manufacturer and marketer of nutritional supplements. Its primary business activity is to provide private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbs, and other nutritional supplements, as well as other health care products, to consumers both within and outside the United States. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer ecommerce channels, and retail stores. It manufactures products in a variety of forms, including capsules, tablets, chewable wafers, and powders to accommodate a variety of its customer’s preferences. It also seeks to commercialize its patent and trademarks through the direct distribution and sale of CarnoSyn, SR CarnoSyn, TriBsyn, new contract manufacturing opportunities, and various license, royalty, and similar arrangements.
估值合理
公司最新PE估值-1.61,处于3年历史合理位
机构减仓
最新机构持股2.06M股,环比减少4.12%
詹姆斯·西蒙斯持仓
明星投资者詹姆斯·西蒙斯持仓,最新持仓市值291.86K

Natural Alternatives International Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Natural Alternatives International Inc简介

Natural Alternatives International, Inc. is a formulator, manufacturer and marketer of nutritional supplements. Its primary business activity is to provide private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbs, and other nutritional supplements, as well as other health care products, to consumers both within and outside the United States. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer ecommerce channels, and retail stores. It manufactures products in a variety of forms, including capsules, tablets, chewable wafers, and powders to accommodate a variety of its customer’s preferences. It also seeks to commercialize its patent and trademarks through the direct distribution and sale of CarnoSyn, SR CarnoSyn, TriBsyn, new contract manufacturing opportunities, and various license, royalty, and similar arrangements.
公司代码NAII
公司Natural Alternatives International Inc
CEOLedoux (Mark A)
网址https://www.nai-online.com/

常见问题

Natural Alternatives International Inc(NAII)的当前股价是多少?

Natural Alternatives International Inc(NAII)的当前股价是 3.220。

Natural Alternatives International Inc的股票代码是什么?

Natural Alternatives International Inc的股票代码是NAII。

Natural Alternatives International Inc股票的52周最高点是多少?

Natural Alternatives International Inc股票的52周最高点是4.400。

Natural Alternatives International Inc股票的52周最低点是多少?

Natural Alternatives International Inc股票的52周最低点是2.570。

Natural Alternatives International Inc的市值是多少?

Natural Alternatives International Inc的市值是19.89M。

Natural Alternatives International Inc的净利润是多少?

Natural Alternatives International Inc的净利润为-13.57M。

现在Natural Alternatives International Inc(NAII)的股票是买入、持有还是卖出?

根据分析师评级,Natural Alternatives International Inc(NAII)的总体评级为--,目标价格为--。

Natural Alternatives International Inc(NAII)股票的每股收益(EPS TTM)是多少

Natural Alternatives International Inc(NAII)股票的每股收益(EPS TTM)是-1.996。
KeyAI